Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 22:6:12.
doi: 10.1186/s13601-016-0099-6. eCollection 2016.

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review

Affiliations

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review

Sangeeta Dhami et al. Clin Transl Allergy. .

Erratum in

  • Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.
    Dhami S, Nurmatov U, Roberts G, Pfaar O, Muraro A, Ansotegui IJ, Calderon M, Cingi C, Demoly P, Durham S, van Wijk RG, Halken S, Hamelmann E, Hellings P, Jacobsen L, Knol E, Linnemann DL, Lin S, Maggina V, Oude-Elberink H, Pajno G, Panwankar R, Pastorello E, Pitsios C, Rotiroti G, Timmermans F, Tsilochristou O, Varga EM, Wilkinson J, Williams A, Worm M, Zhang L, Sheikh A. Dhami S, et al. Clin Transl Allergy. 2017 Sep 15;7:29. doi: 10.1186/s13601-017-0168-5. eCollection 2017. Clin Transl Allergy. 2017. PMID: 28932383 Free PMC article.

Abstract

Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis.

Methods: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.

Conclusion: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.

Keywords: Allergen immunotherapy; Allergic rhinoconjunctivitis; Allergy; Rhinitis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Conceptualization of systematic review of allergen immunotherapy for allergic rhinoconjunctivitis

References

    1. Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A, ISAAC Phase Three Study Group The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol. 2013;41:73–85. doi: 10.1016/j.aller.2012.03.001. - DOI - PubMed
    1. Patil VK, Kurukulaaratchy RJ, Venter C, Grundy J, Roberts G, Dean T, et al. Changing prevalence of wheeze, rhinitis and allergic sensitisation in late childhood: findings from 2 Isle of Wight birth cohorts 12 years apart. Clin Exp Allergy. 2015;45:1430–1438. doi: 10.1111/cea.12534. - DOI - PubMed
    1. Bousquet PJ, Demoly P, Devillier P, Mesbah K, Bousquet J. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol. 2013;160:393–400. doi: 10.1159/000342991. - DOI - PubMed
    1. Brożek Jan L, Bousquet Jean, Baena-Cagnani Carlos E, Bonini Sergio, Canonica GW, Casale TB, van Wijk RG, Ohta K. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol. 2010;126(3):p466–p476. doi: 10.1016/j.jaci.2010.06.047. - DOI - PubMed
    1. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1 Suppl):S2–S8. doi: 10.1067/mai.2001.115569. - DOI - PubMed